Financial Incentives for Smoking Treatment II
Launched by UNIVERSITY OF CALIFORNIA, LOS ANGELES · Jun 6, 2019
Trial Information
Current as of September 10, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. age ≥ 18 years
- • 2. smoked tobacco during the prior 30 days,
- • 3. have an active U.S. phone number and address,
- • 4. can provide consent in English or Spanish and
- • 5. are in at least the contemplative stage of change for quitting smoking, as assessed by a single measure, readiness to quit
- Exclusion Criteria:
- • 1. use only smokeless tobacco,
- • 2. are pregnant or breastfeeding,
- • 3. are discharged to an institution (e.g., nursing home, long-term care facility),
- • 4. are unable to provide informed consent, or do not have cognitive ability to enroll or participate in the study
About University Of California, Los Angeles
The University of California, Los Angeles (UCLA) is a prestigious academic institution renowned for its commitment to research and innovation in the biomedical field. As a clinical trial sponsor, UCLA leverages its cutting-edge facilities, expert faculty, and collaborative environment to advance medical knowledge and improve patient care. The university is dedicated to conducting rigorous clinical research that adheres to the highest ethical standards, aiming to translate scientific discoveries into effective therapies and interventions. Through its diverse array of clinical trials, UCLA seeks to address critical health challenges while fostering the development of future healthcare leaders.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
New York, New York, United States
Los Angeles, California, United States
Patients applied
Trial Officials
Joseph Ladapo, MD, PhD
Principal Investigator
University of California, Los Angeles
Scott Sherman, MD
Principal Investigator
NYU Langone Health
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials